Listed

Nuo Therapeutics, Inc.

AURXOTCCIK 1091596HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.8m, Q2 FY2026
Operating income−$166.6k, Q2 FY2026
Net income−$277.6k, Q2 FY2026
Nuo Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k232Revenue, Q3 FY2023, three months to 2023-09-30$232.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure197Revenue, Q4 FY2023, three months to 2023-12-31$197.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure235Revenue, Q1 FY2024, three months to 2024-03-31$234.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure365Revenue, Q2 FY2024, three months to 2024-06-30$364.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure371Revenue, Q3 FY2024, three months to 2024-09-30$371.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure395Revenue, Q4 FY2024, three months to 2024-12-31$394.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure484Revenue, Q1 FY2025, three months to 2025-03-31$484.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure700Revenue, Q2 FY2025, three months to 2025-06-30$700.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure1,032Revenue, Q3 FY2025, three months to 2025-09-30$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure1,097Revenue, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure1,302Revenue, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,769Revenue, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Cost of revenue$k53.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$53.8k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure41.4Cost of revenue, Q4 FY2023, three months to 2023-12-31$41.4k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure50.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$50.6k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure65.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$65.3k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure101Cost of revenue, Q3 FY2024, three months to 2024-09-30$100.5k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure86.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$86.4k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure121Cost of revenue, Q1 FY2025, three months to 2025-03-31$121.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure159Cost of revenue, Q2 FY2025, three months to 2025-06-30$159.3k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure407Cost of revenue, Q3 FY2025, three months to 2025-09-30$406.7k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure408Cost of revenue, Q4 FY2025, three months to 2025-12-31$408.5k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure452Cost of revenue, Q1 FY2026, three months to 2026-03-31$452.4k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure599Cost of revenue, Q2 FY2026, three months to 2026-06-30$599.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Gross profit$k178Gross profit, Q3 FY2023, three months to 2023-09-30$178.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure156Gross profit, Q4 FY2023, three months to 2023-12-31$155.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure184Gross profit, Q1 FY2024, three months to 2024-03-31$184.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure299Gross profit, Q2 FY2024, three months to 2024-06-30$299.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure270Gross profit, Q3 FY2024, three months to 2024-09-30$270.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure308Gross profit, Q4 FY2024, three months to 2024-12-31$308.5k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure363Gross profit, Q1 FY2025, three months to 2025-03-31$363.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure541Gross profit, Q2 FY2025, three months to 2025-06-30$540.9k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure625Gross profit, Q3 FY2025, three months to 2025-09-30$625.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure688Gross profit, Q4 FY2025, three months to 2025-12-31$688.4k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure850Gross profit, Q1 FY2026, three months to 2026-03-31$849.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,170Gross profit, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Research and development$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$k968Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$968.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure808Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$807.8k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure893Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$893.2k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure841Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$841.4k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure848Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$847.8k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure938Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$937.7k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure1,109Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,193Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure1,166Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure1,268Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure1,296Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,337Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Operating income$k(790)Operating income, Q3 FY2023, three months to 2023-09-30−$789.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure(652)Operating income, Q4 FY2023, three months to 2023-12-31−$652.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure(709)Operating income, Q1 FY2024, three months to 2024-03-31−$709.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure(542)Operating income, Q2 FY2024, three months to 2024-06-30−$542.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure(577)Operating income, Q3 FY2024, three months to 2024-09-30−$577.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(629)Operating income, Q4 FY2024, three months to 2024-12-31−$629.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure(745)Operating income, Q1 FY2025, three months to 2025-03-31−$745.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure(652)Operating income, Q2 FY2025, three months to 2025-06-30−$652.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(540)Operating income, Q3 FY2025, three months to 2025-09-30−$540.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(579)Operating income, Q4 FY2025, three months to 2025-12-31−$579.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure(446)Operating income, Q1 FY2026, three months to 2026-03-31−$446.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure(167)Operating income, Q2 FY2026, three months to 2026-06-30−$166.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(791)Net income, Q3 FY2023, three months to 2023-09-30−$790.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure(653)Net income, Q4 FY2023, three months to 2023-12-31−$653.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure(709)Net income, Q1 FY2024, three months to 2024-03-31−$708.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(540)Net income, Q2 FY2024, three months to 2024-06-30−$540.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(578)Net income, Q3 FY2024, three months to 2024-09-30−$578.2k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(497)Net income, Q4 FY2024, three months to 2024-12-31−$496.7k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure(746)Net income, Q1 FY2025, three months to 2025-03-31−$746.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(650)Net income, Q2 FY2025, three months to 2025-06-30−$649.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(538)Net income, Q3 FY2025, three months to 2025-09-30−$537.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(578)Net income, Q4 FY2025, three months to 2025-12-31−$578.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure(618)Net income, Q1 FY2026, three months to 2026-03-31−$618.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(278)Net income, Q2 FY2026, three months to 2026-06-30−$277.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.02)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figurenot reported(0.02)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure(0.01)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure(0.01)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figurenot reported(0.02)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure(0.01)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(0.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figurenot reported(0.01)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure(0.01)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure

Balance sheet

Cash and equivalents$449.3k, Q2 FY2026
Shareholders' equity−$1.5m, Q2 FY2026
Nuo Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$k583Cash and equivalents, Q3 FY2023, at 2023-09-30$582.6k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure929Cash and equivalents, FY2023, at 2023-12-31$928.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-04-01, accession 0001437749-25-010379.Report this figure366Cash and equivalents, Q1 FY2024, at 2024-03-31$366.2k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001437749-24-017125.Report this figure473Cash and equivalents, Q2 FY2024, at 2024-06-30$473.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001437749-24-025952.Report this figure684Cash and equivalents, Q3 FY2024, at 2024-09-30$683.8k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure284Cash and equivalents, FY2024, at 2024-12-31$283.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure55.7Cash and equivalents, Q1 FY2025, at 2025-03-31$55.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure316Cash and equivalents, Q2 FY2025, at 2025-06-30$316.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure515Cash and equivalents, Q3 FY2025, at 2025-09-30$514.8k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure549Cash and equivalents, FY2025, at 2025-12-31$548.9k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure264Cash and equivalents, Q1 FY2026, at 2026-03-31$263.8k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure449Cash and equivalents, Q2 FY2026, at 2026-06-30$449.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Current assets$k1,258Current assets, Q3 FY2023, at 2023-09-30$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-20, accession 0001437749-23-032632.Report this figure1,563Current assets, FY2023, at 2023-12-31$1.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-04-01, accession 0001437749-25-010379.Report this figure981Current assets, Q1 FY2024, at 2024-03-31$981.1k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017125.Report this figure1,175Current assets, Q2 FY2024, at 2024-06-30$1.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001437749-24-025952.Report this figure1,343Current assets, Q3 FY2024, at 2024-09-30$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure842Current assets, FY2024, at 2024-12-31$841.5k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure602Current assets, Q1 FY2025, at 2025-03-31$601.5k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure853Current assets, Q2 FY2025, at 2025-06-30$853.3k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure1,463Current assets, Q3 FY2025, at 2025-09-30$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure1,380Current assets, FY2025, at 2025-12-31$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure1,520Current assets, Q1 FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,993Current assets, Q2 FY2026, at 2026-06-30$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Total assets$k1,600Total assets, Q3 FY2023, at 2023-09-30$1.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-20, accession 0001437749-23-032632.Report this figure1,878Total assets, FY2023, at 2023-12-31$1.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-04-01, accession 0001437749-25-010379.Report this figure1,243Total assets, Q1 FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001437749-24-017125.Report this figure1,420Total assets, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001437749-24-025952.Report this figure1,719Total assets, Q3 FY2024, at 2024-09-30$1.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure1,190Total assets, FY2024, at 2024-12-31$1.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure1,147Total assets, Q1 FY2025, at 2025-03-31$1.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure1,359Total assets, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure1,928Total assets, Q3 FY2025, at 2025-09-30$1.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure1,846Total assets, FY2025, at 2025-12-31$1.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure1,946Total assets, Q1 FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure2,626Total assets, Q2 FY2026, at 2026-06-30$2.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Current liabilities$k685Current liabilities, Q3 FY2023, at 2023-09-30$685.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-20, accession 0001437749-23-032632.Report this figure675Current liabilities, FY2023, at 2023-12-31$674.5k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-04-01, accession 0001437749-25-010379.Report this figure761Current liabilities, Q1 FY2024, at 2024-03-31$761.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017125.Report this figure690Current liabilities, Q2 FY2024, at 2024-06-30$690.4k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001437749-24-025952.Report this figure714Current liabilities, Q3 FY2024, at 2024-09-30$714.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure578Current liabilities, FY2024, at 2024-12-31$578.5k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure1,281Current liabilities, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure999Current liabilities, Q2 FY2025, at 2025-06-30$999.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure1,256Current liabilities, Q3 FY2025, at 2025-09-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure1,306Current liabilities, FY2025, at 2025-12-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure1,369Current liabilities, Q1 FY2026, at 2026-03-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1,554Current liabilities, Q2 FY2026, at 2026-06-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Total liabilities$k873Total liabilities, Q3 FY2023, at 2023-09-30$873.2k. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-20, accession 0001437749-23-032632.Report this figure839Total liabilities, FY2023, at 2023-12-31$838.7k. XBRL concept us-gaap:Liabilities. 10-K filed 2025-04-01, accession 0001437749-25-010379.Report this figure909Total liabilities, Q1 FY2024, at 2024-03-31$909.4k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001437749-24-017125.Report this figure822Total liabilities, Q2 FY2024, at 2024-06-30$822.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001437749-24-025952.Report this figure829Total liabilities, Q3 FY2024, at 2024-09-30$828.7k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure676Total liabilities, FY2024, at 2024-12-31$675.8k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure1,360Total liabilities, Q1 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure2,184Total liabilities, Q2 FY2025, at 2025-06-30$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001437749-25-024043.Report this figure2,347Total liabilities, Q3 FY2025, at 2025-09-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure2,802Total liabilities, FY2025, at 2025-12-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure3,330Total liabilities, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure4,162Total liabilities, Q2 FY2026, at 2026-06-30$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure
Long-term debt$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$k727Shareholders' equity, Q3 FY2023, at 2023-09-30$726.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001437749-24-034325.Report this figure1,039Shareholders' equity, FY2023, at 2023-12-31$1.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001437749-26-010360.Report this figure333Shareholders' equity, Q1 FY2024, at 2024-03-31$333.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure599Shareholders' equity, Q2 FY2024, at 2024-06-30$598.5k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure890Shareholders' equity, Q3 FY2024, at 2024-09-30$890.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure514Shareholders' equity, FY2024, at 2024-12-31$513.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(213)Shareholders' equity, Q1 FY2025, at 2025-03-31−$213.1k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(825)Shareholders' equity, Q2 FY2025, at 2025-06-30−$824.6k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(420)Shareholders' equity, Q3 FY2025, at 2025-09-30−$419.6k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001437749-25-032437.Report this figure(957)Shareholders' equity, FY2025, at 2025-12-31−$956.6k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(1,384)Shareholders' equity, Q1 FY2026, at 2026-03-31−$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure(1,535)Shareholders' equity, Q2 FY2026, at 2026-06-30−$1.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure

Cash flow

Operating cash flow−$236.5k, Q2 FY2026
Capital expenditure$253.0k, Q2 FY2026
Nuo Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(795)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$794.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001437749-24-034325. Derived: 9-month figure less the 6-month figure.Report this figure(671)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$671.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure(562)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$562.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure(691)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$691.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001437749-25-024043. Derived: 6-month figure less the 3-month figure.Report this figure(487)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$487.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001437749-25-032437. Derived: 9-month figure less the 6-month figure.Report this figure(491)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$490.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure1.8Operating cash flow, Q1 FY2025, three months to 2025-03-31$1.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure262Operating cash flow, Q2 FY2025, three months to 2025-06-30$262.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001437749-26-028053. Derived: 6-month figure less the 3-month figure.Report this figure(707)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$706.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001437749-25-032437. Derived: 9-month figure less the 6-month figure.Report this figure(423)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$422.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure(784)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$784.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure(236)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$236.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001437749-26-028053. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k1.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001437749-24-034325. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-04-01, accession 0001437749-25-010379. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-30, accession 0001437749-25-013653.Report this figure4.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001437749-25-024043. Derived: 6-month figure less the 3-month figure.Report this figure151Capital expenditure, Q3 FY2024, three months to 2024-09-30$150.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001437749-25-032437. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure230Capital expenditure, Q1 FY2025, three months to 2025-03-31$229.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure1.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001437749-26-028053. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001437749-25-032437. Derived: 9-month figure less the 6-month figure.Report this figure43.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$43.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001437749-26-010360. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$847. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017104.Report this figure253Capital expenditure, Q2 FY2026, three months to 2026-06-30$253.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001437749-26-028053. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)30.26m, Q3 FY2021
Nuo Therapeutics, Inc., shares, quarterly
Line itemUnitQ1 FY20182018-03-31Q2 FY20182018-06-30Q3 FY20182018-09-30Q1 FY20192019-03-31Q2 FY20192019-06-30Q3 FY20192019-09-30period not labelled2020-03-31period not labelled2020-06-30period not labelled2020-09-30period not labelled2021-03-31period not labelled2021-06-30Q3 FY20212021-09-30
Diluted shares (weighted)m shares22.7Diluted shares (weighted), Q1 FY2018, three months to 2018-03-3122,722,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2019-05-20, accession 0001437749-19-010509.Report this figure22.9Diluted shares (weighted), Q2 FY2018, three months to 2018-06-3022,931,191 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2019-08-19, accession 0001437749-19-017108.Report this figure23.7Diluted shares (weighted), Q3 FY2018, three months to 2018-09-3023,722,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2020-01-31, accession 0001437749-20-001481.Report this figure23.7Diluted shares (weighted), Q1 FY2019, three months to 2019-03-3123,722,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2019-05-20, accession 0001437749-19-010509.Report this figure23.7Diluted shares (weighted), Q2 FY2019, three months to 2019-06-3023,722,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2019-08-19, accession 0001437749-19-017108.Report this figure23.7Diluted shares (weighted), Q3 FY2019, three months to 2019-09-3023,722,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2020-01-31, accession 0001437749-20-001481.Report this figure30.5Diluted shares (weighted), period not labelled, three months to 2020-03-3130,460,299 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure24.2Diluted shares (weighted), period not labelled, three months to 2020-06-3024,247,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure24.2Diluted shares (weighted), period not labelled, three months to 2020-09-3024,247,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure30.3Diluted shares (weighted), period not labelled, three months to 2021-03-3130,258,744 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure30.3Diluted shares (weighted), period not labelled, three months to 2021-06-3030,258,744 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure30.3Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3030,258,744 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-04-15, accession 0001437749-22-009050.Report this figure

Shares outstanding: 48.43mShares outstanding, period not labelled, at 2026-08-1248,433,777 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001437749-26-028053.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.